000 | 01928 a2200565 4500 | ||
---|---|---|---|
005 | 20250517191631.0 | ||
264 | 0 | _c20190204 | |
008 | 201902s 0 0 eng d | ||
022 | _a1938-0682 | ||
024 | 7 |
_a10.1016/j.clgc.2017.10.017 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVerbiest, Annelies | |
245 | 0 | 0 |
_aMolecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting. _h[electronic resource] |
260 |
_bClinical genitourinary cancer _c06 2018 |
||
300 |
_ae605-e612 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xclassification |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndazoles |
650 | 0 | 4 |
_aKidney Neoplasms _xclassification |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aProgression-Free Survival |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCouchy, Gabrielle | |
700 | 1 | _aJob, Sylvie | |
700 | 1 | _aZucman-Rossi, Jessica | |
700 | 1 | _aCaruana, Laure | |
700 | 1 | _aLerut, Evelyne | |
700 | 1 | _aOyen, Raymond | |
700 | 1 | _ade Reyniès, Aurélien | |
700 | 1 | _aLaguerre, Brigitte | |
700 | 1 | _aRioux-Leclercq, Nathalie | |
700 | 1 | _aWozniak, Agnieszka | |
700 | 1 | _aJoniau, Steven | |
700 | 1 | _aVan Poppel, Hendrik | |
700 | 1 | _aVan Den Eynde, Kathleen | |
700 | 1 | _aBeuselinck, Benoit | |
773 | 0 |
_tClinical genitourinary cancer _gvol. 16 _gno. 3 _gp. e605-e612 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clgc.2017.10.017 _zAvailable from publisher's website |
999 |
_c27888240 _d27888240 |